SAS and The Washington Post shine light on the opioid epidemic, including role of analytics

1

Tune into The Washington Post Live event about the opioid epidemic. Learn how analytics can help.

The opioid epidemic continues to be one of the largest challenges facing the United States. In 2016, more than 42,000 Americans died from opioid overdoses, and that number continues to climb. Recent data shows that more than 130 people die every day in the United States after overdosing on opioids, according to the National Center for Health Statistics.

NOTE: THIS HAS BEEN RESCHEDULED TO FRIDAY, DEC. 7 AT 9 A.M. IN OBSERVANCE OF THE NATIONAL DAY OF MOURNING FOR PRESIDENT GEORGE H.W. BUSH

While there is no single solution to prevent substance use disorder, analytics wielded by federal, state and local governments are leading to meaningful change. That, and other key topics, will drive the discussion on December 7 during The Washington Post Live event – “Addiction in America: The New War on Drugs.” Kicking off at 9 a.m. eastern, the event will be live streamed so that individuals involved in, and anyone concerned with, the opioid epidemic can engage.

Dr. Jerome Adams, the US Surgeon General, will discuss the federal government’s efforts to tackle the crisis, including the latest proposals from the administration to fund and implement treatment and prevention programs. Other notable speakers responsible for helping to manage this crisis have also been invited to present.

For SAS, it’s a chance to discuss how analytics is informing health policy, and to present use cases.

Analytics go beyond simple statistics to provide predictions that can help identify growing trends. Analytics can find relationships in data that human analysts might normally miss, or help identify growing areas of concern before they become problematic. Finally, analytics can be used to review programs already in place to see if they are creating the desired outcomes.

Among the innovative examples of analytics,  SAS US Government Medical Director, Steve Kearney, will discuss the importance of public-private partnerships and highlight a toolkit for using prescription drug claims to analyze patients’ opioid prescription levels. Recently published by the US Department of Health and Human Services, the toolkit applies SAS software code to Medicare Part D data to identify over-prescribers and people at risk of addiction. (Learn more about the toolkit in today's announcement.)

For example, HHS OIG analyses uncovered a Louisiana Medicare beneficiary who received 52 opioid prescriptions from 23 pharmacies in four states. In Florida, a physician ordered 33 prescriptions for one individual, including 11 months of fentanyl and oxycodone.

These cases just scratch the surface of the epidemic. We look forward to taking part in this conversation with The Washington Post. The event will be an important place for leaders to share best practices, highlight new and emerging trends, and continue to come up with solutions to this evolving epidemic.

If you’re interested in tuning into the livecast, visit the website for registration details.

Share

About Author

Steve Kearney

Medical Director, SAS State and Local Government

As Medical Director for SAS US Government and Education, Dr. Steve Kearney leads the company's efforts to help Federal Agencies, State and Local Governments as well as Universities use analytics to reduce costs and improve citizen health outcomes. A veteran of private and public sector health care, Kearney was a Director of the Medical Outcomes Specialists group at Pfizer Global Medical, where he advised on clinical matters, health information technology, patient outcomes and policy for states, integrated delivery networks, payers, providers and patients. Kearney also served on the North Carolina Governor’s Task Force for Heart Disease and Stroke Prevention and NC Medicaid's Behavioral Health Subcommittee.

1 Comment

Leave A Reply

Back to Top